Buscar
Mostrando ítems 1-6 de 6
Artículo
Sofosbuvir shows a protective effect against vertical transmission of Zika virus and the associated congenital syndrome in rhesus monkeys
| Fecha del documento:
2020 | Derechos de autor:
restricted access
Artículo
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Fecha del documento:
2021 | Derechos de autor:
open access
Artículo
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Fecha del documento:
2017 | Derechos de autor:
open access
Artículo
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
| Fecha del documento:
2017 | Derechos de autor:
open access
Artículo
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
| Fecha del documento:
2019 | Derechos de autor:
open access
Artículo
Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS-331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika
| Fecha del documento:
2023 | Derechos de autor:
restricted access